Human lung organoids model for assessing host response to Mycobacterium tuberculosis infection
Open Access
- 10 February 2026
- journal article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16
Abstract
Introduction: Airway and alveolar epithelial cells serve as the primary defense in the lower respiratory tract, yet their exact role in Mycobacterium tuberculosis (Mtb) infection is incompletely understood. Given that Mtb is a human-restricted pathogen, a representative human model is required. Lung organoids (LOs), which are composed of various epithelial cells, mesenchymal cells, and extracellular matrix, facilitate the investigation of bacterial infections. Methods: In this study, we established an Mtb infection model using human induced pluripotent stem cells (iPSCs)-derived LOs. Results: Prolonged infection led to the gradual invasion of Mtb from the periphery to the interior of the organoid, leading to decreased viability and the induction of fibrotic responses. Transcriptomic and protein analyses suggest that Mtb infection triggered a TLR4/NF-κB-associated inflammatory response. Additionally, the elevation of antimicrobial peptides and the release of diverse pro-inflammatory cytokines and chemokines were noted in the infected LOs. Conclusion: These findings emphasize the potential role of LOs in host defense and demonstrate that the Mtb -infected lung organoid model provides a novel platform for elucidating the role of pulmonary structural cells in tuberculosis pathogenesis. Furthermore, this model opens new avenues for the development of molecular therapeutic strategies.Keywords
This publication has 42 references indexed in Scilit:
- Research progress of lung organoids in infectious respiratory diseasesEuropean Journal of Pharmacology, 2025
- Modeling Mycobacterium tuberculosis pathogenesis in lung epithelial organoids reveals strain-specific host responses and intercellular crosstalkJournal of Biological Chemistry, 2025
- An organoid co-culture model for probing systemic anti-tumor immunity in lung cancerCell Stem Cell, 2025
- Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung InjuryInflammation, 2022
- Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patientsInfection, 2022
- Innate immune sensing by epithelial barriersCurrent Opinion in Immunology, 2021
- The Applicability of Mouse Models to the Study of Human Disease2019
- Comparative study of interruption of signaling pathways in lung epithelial cell by two different Mycobacterium tuberculosis lineagesJournal of Cellular Physiology, 2018
- Mycobacterium tuberculosis Rv2185c contributes to nuclear factor-κB activationMolecular Immunology, 2015
- Signaling to NF-κB by Toll-like receptorsTrends in Molecular Medicine, 2007